Clinical Trial Update: Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP [Phase 1]

View source ↗

Summary

Phase I safety and tolerability study of Staphylococcal Protein A in adults with chronic idiopathic thrombocytopenic purpura has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura

Drugs mentioned

• Staphylococcal Protein A (Staphylococcal protein A)

Snippet

Sponsor: Protalex, Inc. | Conditions: Idiopathic Thrombocytopenic Purpura (ITP) | Phase 1 | Status: TERMINATED